Search

Your search keyword '"Kamal Chamoun"' showing total 7 results
Start Over "Kamal Chamoun" Publication Type News
7 results on '"Kamal Chamoun"'

1. New Myelofibrosis Research from University of Utah Discussed (A phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-naive myelofibrosis)

Subjects
Medical research, Medicine, Experimental, Hematopoietic stem cells -- Research, Health, The University of Utah
Abstract

2023 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on myelofibrosis. According to news reporting from Salt Lake City, Utah, [...]

Published
2023

3. Amsterdam University Medical Center Researchers Yield New Study Findings on B-Cell Lymphoma (The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study)

Subjects
Biochemistry -- Analysis -- Reports, Medical research -- Analysis -- Reports, Medicine, Experimental -- Analysis -- Reports, Medical centers -- Analysis -- Reports, Lymphomas -- Reports -- Analysis, Health
Abstract

2022 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on B-cell lymphoma. According to news reporting out of Amsterdam, Netherlands, [...]

Published
2022

4. New Findings from Institute Jules Bordet in the Area of B-Cell Lymphoma Described (Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study)

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Lymphomas -- Care and treatment -- Patient outcomes, Health
Abstract

2021 AUG 2 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on B-cell lymphoma. According to news originating from the Institute Jules [...]

Published
2021

5. University Hospitals Seidman Cancer Center Researchers Release New Data on Multiple Myeloma (Socioeconomic Factors and Survival of Multiple Myeloma Patients)

Subjects
Oncology, Experimental, Hematopoietic stem cells -- Transplantation, Multiple myeloma -- Patient outcomes, Cancer -- Patient outcomes -- Research, Business, Health, Health care industry
Abstract

2021 FEB 23 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in multiple myeloma. According to news originating from the University Hospitals [...]

Published
2021

6. Private Insurance, Higher Regional Incomes, and Certain Practice Settings Predict Longer Survival for People With Multiple Myeloma

Subjects
Ixazomib, Panobinostat, Multiple myeloma, Insurance, Databases, Cancer research, Medical economics, Professional associations, Insurance industry, General interest, News, opinion and commentary, American Society of Clinical Oncology
Abstract

Alexandria, Virginia: Asco has issued the following press release: A new study analyzing demographic statistics from the National Cancer Database identified multiple socio-economic factors, including private insurance, living in a [...]

Published
2019

7. PRIVATE INSURANCE, HIGHER REGIONAL INCOMES, AND CERTAIN PRACTICE SETTINGS PREDICT LONGER SURVIVAL FOR PEOPLE WITH MULTIPLE MYELOMA

Subjects
Ixazomib -- Reports, Cancer research -- Reports, Panobinostat -- Reports, Multiple myeloma -- Reports, Insurance -- Reports, Databases, Social class, Professional associations, Insurance industry, News, opinion and commentary
Abstract

CHICAGO -- The following information was released by the American Society of Clinical Oncology: ASCO Perpectives 'Where you live and what insurance you have should not affect the length of [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results